U.S. automobile brands in Europe registered strong gains in November as Volkswagen continued to suffer due to subdued demand after the diesel emissions scandal.
African-Americans say the discrimination they face in retail stores remains woefully unexamined. Now, some executives and activists are demanding change.
A new survey released Tuesday highlights a sense of pessimism among the American workforce that has lingered since the Great Recession.
The deal is part of GE's plan to sell off the about $200 billion worth of assets of its finance arm, GE Capital.
Economists said the U.S. central bank's monetary easing would generate runaway inflation and financial bubbles. They were wrong.
The proposed exchange would make French drugmaker Sanofi the market leader in the consumer healthcare division.
Housing prices, which surged at double-digit growth rates across major Australian cities in the last two years are set to cool off, according to a report by a property search firm.
The savings hinge on their transaction being a rare merger of equals, which requires companies of the same size and scope, tax experts say.
Former Yahoo executives Ross Levinsohn and Jacqueline Reses are pitched as possible replacements for embattled boss Marissa Mayer.
The U.S. oil benchmark jumped 1.9 percent, its first gain since OPEC nations failed to agree to cut production to boost prices.
The plan approved by the city council Monday marks an aggressive attempt to bring labor protections to gig economy workers.
Nervousness is growing in global markets before an expected U.S. interest rate hike later this week.
The agreement ended months of speculation over the fate of the iconic Italian car designer, known for its work with Ferrari.
Newell Rubbermaid said it expects the deal to expand its presence in food and beverage, baby products and kitchen appliances.
The British drugmaker has shown interest in Acerta's anti cancer treatments, particularly an experimental drug called Acalabrutinib.
The $70 billion deal cleared its final regulatory hurdle Monday after Chinese regulators approved the tie-up.
Toshiba blames the unstable ruble and tough competition from LG and Samsung for leaving the consumer market in Russia.
The move comes four months after activist investor Carl Icahn announced an 8 percent stake and placed two lieutenants on the company's board.
According to a Bank of Japan survey, corporations are positive about the future despite global headwinds and weak domestic consumption.
The Chinese giant is acquiring Hong Kong's 112-year-old flagship newspaper and other media properties.
Oil is trading below $36 per barrel and two U.S. funds suspended redemptions before the Federal Reserve is expected to raise interest rates for the first time in nine years.
Investors seeking guidance on how to deal with the anticipated first U.S. interest-rate hike in a decade will struggle to find any helpful comparisons in history.
Chinese consumers bought more fully electric cars in 10 months than the U.S.-based Tesla Motors Inc. has sold in its 12-year history.
Deep in the historic climate-change agreement is an inelegant reference to what some analysts believe could eventually build a bridge to a global CO2-emissions trading mechanism.
Martin Shkreli's bid for approval to market a Chagas disease treatment isn't all about the FDA voucher he could sell, but he would be willing to sell it, he says.
In the wake of the new climate-change agreement, enthusiasm for sustainable energy-producing alternatives is likely to swell. Here are a few possibilities.
The country’s industrial production, retail sales and new-loans growth surpassed analysts' expectations in November.
The deal, likely to be signed next week, comes months after GE sold its financial businesses in New Zealand, Australia and the U.S. in a drive to become a "simpler" industrial business.
Retail sales slowed in September and October, but better income prospects are helping to revive consumer sentiment.
Acerta, based in the Netherlands, is developing cancer drugs that use the body's own defenses against the disease.